- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Tutankhamun’s Antimalarial Drug for Covid-19 ; year:2020
Drug research ; (2020)
- Beteiligte Personen und Organisationen
-
Sommer, Andrei P.
Försterling, Horst-Dieter
Sommer, Katlin E.
- DOI
-
10.1055/a-1274-1264
- URN
-
urn:nbn:de:101:1-2020122113001045282045
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sommer, Andrei P.
- Försterling, Horst-Dieter
- Sommer, Katlin E.
Ähnliche Objekte (12)
Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
Hydroxychloroquine – An Antimalarial to Fight COVID-19?
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications
Antimalarial drugs: unexpected evolutionary consequences
World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
Drug resistance genomics of the antimalarial drug artemisinin
Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
A database of antimalarial drug resistance
The threat of antimalarial drug resistance
Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs
The global challenge of antimalarial drug resistance
Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
Hydroxychloroquine – An Antimalarial to Fight COVID-19?
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications
Antimalarial drugs: unexpected evolutionary consequences
World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
Drug resistance genomics of the antimalarial drug artemisinin
Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
A database of antimalarial drug resistance
The threat of antimalarial drug resistance
Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs
The global challenge of antimalarial drug resistance
Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
Hydroxychloroquine – An Antimalarial to Fight COVID-19?
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications
Antimalarial drugs: unexpected evolutionary consequences
World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
Drug resistance genomics of the antimalarial drug artemisinin
Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
A database of antimalarial drug resistance
The threat of antimalarial drug resistance
Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs